GC BIOPHARMA
Live / Registered — Registered (as of 24 Feb 2026)
What this means for you
Registered since 24 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97298515
- Registration number
- 8152205
- Mark type
- Design + words
- Filed
- 07 Mar 2022
- Published for opposition
- 13 Dec 2022
- Registered
- 24 Feb 2026
- Attorney of record
- Kwang Yup Chae
Goods and services
- Class 005 — Pharmaceuticals: Medicines for humans used for the prevention and treatment of Immunodeficiency disease, Human Immunodeficiency Virus, rare disease; Medicines for humans, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Biological preparations for medical or veterinary purposes, namely, biological preparations used for the prevention and treatment of Immunodeficiency disease, Human Immunodeficiency Virus, rare disease; Biological preparations for medical or veterinary purposes, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors
- Class 042 — Scientific and technological services: Research and development of medicines; Research and development, scientific research in the field of pharmaceuticals, blood plasma preparations, recombinant proteins and antibodies; Scientific research in the fields of biomedicine; Research and development in the pharmaceutical and biotechnology fields
Owner
- Green Cross Holdings Corporation, Yongin-si, Gyeonggi-do, KR
- Green Cross Holdings Corporation, Yongin-si, Gyeonggi-do, KR
- Green Cross Holdings Corporation, Yongin-si, Gyeonggi-do, KR
Prior registrations
Prosecution history
- 24 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 05 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Feb 2026 — ASSIGNED TO LIE
- 29 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Nov 2025 — NON-FINAL ACTION E-MAILED
- 14 Nov 2025 — SU - NON-FINAL ACTION - WRITTEN
- 10 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 08 May 2025 — USE AMENDMENT FILED
- 10 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 May 2025 — TEAS STATEMENT OF USE RECEIVED